Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • JASN Podcasts
    • Article Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Editorial Fellowship
    • Editorial Fellowship Team
    • Editorial Fellowship Application Process
  • More
    • About JASN
    • Advertising
    • Alerts
    • Feedback
    • Impact Factor
    • Reprints
    • Subscriptions
  • ASN Kidney News
  • Other
    • ASN Publications
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • ASN Publications
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • JASN Podcasts
    • Article Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Editorial Fellowship
    • Editorial Fellowship Team
    • Editorial Fellowship Application Process
  • More
    • About JASN
    • Advertising
    • Alerts
    • Feedback
    • Impact Factor
    • Reprints
    • Subscriptions
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum
Errata
You have accessRestricted Access

Erratum

JASN September 2016, 27 (9) 2918; DOI: https://doi.org/10.1681/ASN.2016060616
  • Article
  • Info & Metrics
  • View PDF
Loading

Correction

Schneider CA, Ferrannini E, DeFronzo R, Schernthaner G, Yates J, and Erdmann E: Effect of Pioglitazone on Cardiovascular Outcome in Diabetes and Chronic Kidney Disease. J Am Soc Nephrol 19: 182–187, 2008.

Please note the following corrections in the above article published in the January 2008 issue of the Journal of the American Society of Nephrology. In this article, the data errors were caused by (1) description of events at average follow-up rather than overall and (2) a transcription error. Also, the correct version of the Modification of Diet in Renal Disease (MDRD) formula is now described in Concise Methods. These errors do not alter the data interpretation or affect the study conclusions.

The following are corrections to the manuscript.

  • In the third paragraph of Results (p 184), the sentence “All-cause mortality rates were 7.7% (n = 21) in the pioglitazone group and 13.6% (n = 44) in the placebo group (HR, 0.75; 95% CI, 0.55 to 1.03)” should have read “All-cause mortality rates were 8.0% (n = 22) in the pioglitazone group and 13.9% (n = 45) in the placebo group (HR, 0.55; 95% CI, 0.33 to 0.92).”

  • In the fourth paragraph of Results (p 184), the sentence “The proportion of patients who had a GFR≥60 ml/min per 1.73 m2 and subsequently died from any cause was also similar between groups (n = 137 [6.0%] with pioglitazone versus n = 130 [5.7%] with placebo; HR, 1.09; 95% CI, 0.87 to 1.38)” should have read “The proportion of patients who had a GFR≥60 ml/min per 1.73 m2 and subsequently died from any cause was also similar between groups (n = 148 [6.5%] with pioglitazone versus n = 134 [5.9%] with placebo; HR, 1.09; 95% CI, 0.87 to 1.38).”

  • In the first paragraph of Procedures in Concise Methods (p 186), the sentence “GFR was estimated using the simplified MDRD formula: 186.2 × serum creatinine in mg/dl−1.154 × age in yr−0.203 × 1.212 if black × 0.742 if female” should have read “GFR was estimated using the simplified MDRD formula: 186 × serum creatinine in milligrams per deciliter−1.154 × age in years−0.203 × 0.742 for women.”

Footnotes

  • Published online ahead of print. Publication date available at www.jasn.org.

  • Copyright © 2016 by the American Society of Nephrology
PreviousNext
Back to top

In this issue

Journal of the American Society of Nephrology: 27 (9)
Journal of the American Society of Nephrology
Vol. 27, Issue 9
September 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in JASN.
Enter multiple addresses on separate lines or separate them with commas.
Erratum
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Erratum
JASN Sep 2016, 27 (9) 2918; DOI: 10.1681/ASN.2016060616

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Erratum
JASN Sep 2016, 27 (9) 2918; DOI: 10.1681/ASN.2016060616
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Correction
    • Footnotes
  • Info & Metrics
  • View PDF

More in this TOC Section

  • Correction: Mycophenolate Mofetil after Rituximab for Childhood-Onset Complicated Frequently-Relapsing or Steroid-Dependent Nephrotic Syndrome
  • Correction: Megalin Blockade with Cilastatin Suppresses Drug-Induced Nephrotoxicity
  • Correction: Beneficial Effects of Myo-Inositol Oxygenase Deficiency in Cisplatin-Induced AKI
Show more Errata

Cited By...

  • No citing articles found.
  • Google Scholar

Similar Articles

Related Articles

  • Effect of Pioglitazone on Cardiovascular Outcome in Diabetes and Chronic Kidney Disease
  • PubMed
  • Google Scholar

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe to ASN Journals

© 2022 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire